Encouraging to see the stock consistently and opportunistically supported below asset backing. Just a matter of time, particularly in the current market, before the right project is available for this cashed up company.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
